This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pyrah, I. T. Articles by Greaves, P. Search for Related Content PubMed PubMed Citation Articles by Pyrah, I. T. Articles by Greaves, P. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Social Bookmarking                         What's this?

Toxicologic Lesions Associated with Two Related Inhibitors of Oxidosqualene Cyclase in the Dog and Mouse

Safety Assessment, Alderley, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, SK10 4TG, United Kingdom

Adam Kalinowski

Safety Assessment, Alderley, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, SK10 4TG, United Kingdom

David Jackson

Safety Assessment, Alderley, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, SK10 4TG, United Kingdom

Wendy Davies

Safety Assessment, Alderley, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, SK10 4TG, United Kingdom

Stewart Davis

Safety Assessment, Alderley, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, SK10 4TG, United Kingdom

Andrew Aldridge

Safety Assessment, Alderley, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, SK10 4TG, United Kingdom

Peter Greaves

Safety Assessment, Alderley, AstraZeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire, SK10 4TG, United Kingdom

Two novel hypolipidaemic agents, both members of the aminopyrimidine series, with a mode of action of inhibition of oxidosqualene cyclase (OSC), were administered orally to dogs and mice for 14 and 28 days. Both compounds produced a similar spectrum of pathologic changes. In dogs, the agents produced equatorial single cell necrosis and cataract in the lens (also observed clinically); atrophy, ulceration, and infl ammation of the cornea; hyperkeratosis, acanthosis, hair papillary atrophy, and infl ammation of the skin; and epithelial degeneration and sperm granuloma in the epididymides. One female dog showed signs of liver toxicity. In mice, severe cataract formation was seen with both compounds, and liver toxicity was produced by one of the compounds. The severity and speed of onset of the cataract formation were very marked. The changes seen were dissimilar to those reported with the most commonly used class of hypolipidaemic agents in the clinic, the hydroxymethy l glutaryl coenzyme A (HMGCoA) reductase inhibitors but were reminiscent of those reported for the hypolipidaemic agent Triparanol, which was predictive of toxicity seen in man.

Key Words: Cataract • hair loss • hypolipidaemic agent • keratitis • sperm granuloma • hyperkeratosis.

References

• Cenedella RJ (1996). Cholesterol and cataracts. Survey Opthalmol 40: 4, 320—337.[CrossRef]
• Creasy D. (1998). The male reproductive system. In: Target Organ Pathology. Turton J, Hooson J (eds). Taylor and Francis, London, p 396.
• Gerson RJ, MacDonald JS, Alberts AW, Kornblust DJ, Majka JA, Stubbs RJ, Bokelman DL (1989). Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-Coenzym e A reductase inhibitors. Am J Med 87 Suppl 4A: 28S—38S.[Medline] [Order article via Infotrieve]
• Kirby TJ (1967). Cataracts produced by triparanol (MER/29). Transcripts Am Ophthalmol Soc 65: 493—543.
• Kirby TJ, Achor RWP, Perry HO, Winkelmann RK (1962). Cataract formation after triparanol therapy. Arch Ophthalmol 68: 84—87.
• MacDonald JS, Gerson RJ, Kornblust DJ, Kloss MW, Prahalada S., Berry PH, Alberts AW, Bokelman DL (1988). Preclinical evaluation of lovastatin. Am J Cardiol 62: 16J—27J.[CrossRef][Medline] [Order article via Infotrieve]
• Peter JB, Andiman RM, Bowman RL, Nagatomo T. (1973). Myotonia induced by diazacholesterol: increased (Na+ + K+ )-ATPase activity of erythrocyte ghosts and the development of cataracts. Exp Neurol 41: 738— 744.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Reindel JF, Dominick MA, Bocan TMA, Gough AW, McGuire EJ (1994). Toxicologic effects of a novel acyl Co-A: Cholesterol acyltransferase inhibitor in Cynomolgus monkeys. Toxicol Pathol 22(5): 510— 518.
• Roe DA (1966). The effect of hypocholesteremic drugs on the skin. Geriatrics October: 174—182.
• Shepherd J. (1995). Fibrates and statins in the treatment of hyperlipidaemia: An appraisal of their effi cacy and safety. Eur Heart J 16: 5—13.[Abstract/Free Full Text]
• Walsh KM, Albassam MA, Clarke DE (1996). Subchronic toxicity of atorvastatin, a HMGCoA reductase inhibitor, in beagle dogs. Toxicol Pathol 24(4): 468—476.[Abstract/Free Full Text]
• Werner RM, Pearson TA (1998). LDL-cholesterol: A risk factor for coronary artery disease—from epidemiology to clinical trials. Can J Cardiol 14 Suppl B:3B—10B.[Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 29, No. 2, 174-179 (2001)
DOI: 10.1080/019262301317052440


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pyrah, I. T. Articles by Greaves, P. Search for Related Content PubMed PubMed Citation Articles by Pyrah, I. T. Articles by Greaves, P. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Social Bookmarking                         What's this?